🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study of itacitinib (INCB039110) in patients with myelofibrosis. ...
Status
Completed
Location
Birmingham Hematology Oncology Associates, LLC
Start Date
2012-07-16
Trial ID
NCT01633372
Treatments Being Tested
To determine if Itacitinib in combination with corticosteroids is safe and ...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02614612
Treatments Being Tested
This is a study evaluating a 28-day course followed by a 56-day course of i...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01626573
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, pharmacokine...
Status
Terminated
Location
University of California, Los Angeles - David Geffen School of Medicine
Start Date
2020-02-04
Trial ID
NCT03978637
Treatments Being Tested
Open-label, dose-escalation study in subjects with previously treated B-cel...
Status
Completed
Location
University of Alabama At Birmingham Comprehensive Cancer Center
Start Date
2016-09-22
Trial ID
NCT02018861
Treatments Being Tested
This project aims to test the effectiveness of ITACITINIB in sporadic Hemop...
Status
Completed
Location
Hôpital Avicenne
Start Date
2022-05-03
Trial ID
NCT05063110
Treatments Being Tested
This is an open-label, single-group, Phase I/II study of itacitinib in comb...
Status
Active Not Recruiting
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2019-02-11
Trial ID
NCT03697408
Treatments Being Tested